Resources Library
Prometic Announces FDA Acceptance of its BLA For Ryplazim
• Prescription Drug User Fee Act (PDUFA) action date is set for April 14, 2018• Ryplazim™ previously granted Fast Track, […]
October 13, 2017
Atlantic Research Group Forms Rare Disease Strategic Advisory Board to Accelerate Novel Medicines
Atlantic Research Group forms Rare Disease Strategic Advisory Board to accelerate novel medicines. Learn about this collaboration between patient advocacy […]
August 12, 2017
Why “CRA-centricity” Matters For Your Rare Disease Clinical Trial
Rare disease clinical trials also require extraordinary customer service—sometimes even including package delivery. In one case, each treatment dose cost […]
August 4, 2017
ARG to attend the BIO International Convention
ARG to attend the BIO International Convention from 19-22 June 2017 in San Diego, CA. More Information
May 10, 2017
John Boland and Erin Farris to Speak at MAGI East 2017
Come see our speakers at MAGI East 2017! John Boland, VP of Product Development will be speaking about “Managing Clinical […]
May 2, 2017
ARG to Attend The CIS Annual Conference
ARG to attend the CIS (Clinical Immunology Society) Immune Deficiency & Dysregulation North American Conference in Seattle, WA on March […]
February 3, 2017